Literature DB >> 33138626

Impact of the COVID-19 Pandemic on Percutaneous Coronary Intervention in England: Insights From the British Cardiovascular Intervention Society PCI Database Cohort.

Chun Shing Kwok1,2, Chris P Gale3,4,5, Nick Curzen6, Mark A de Belder7, Peter Ludman8, Thomas F Lüscher9,10, Evangelos Kontopantelis11, Chris Roebuck12, Tom Denwood12, Tony Burton12, Julian Hains7, John E Deanfield7,13, Mamas A Mamas1,2.   

Abstract

BACKGROUND: The objective of the study was to evaluate changes in percutaneous coronary intervention (PCI) practice in England by analyzing procedural numbers, changes in the clinical presentation, and characteristics of patients and their clinical outcomes during the coronavirus disease 2019 (COVID-19) pandemic.
METHODS: We conducted a retrospective cohort study of all patients who underwent PCI in England between January 2017 and April 2020 in the British Cardiovascular Intervention Society database.
RESULTS: Forty-four hospitals reported PCI procedures for 126 491 patients. There were ≈700 procedures performed each week before the lockdown. After the March 23, 2020 lockdown (11th/12th week in 2020), there was a 49% fall in the number of PCI procedures after the 12th week in 2020. The decrease was greatest in PCI procedures performed for stable angina (66%), followed by non-ST-segment-elevation myocardial infarction (45%), and ST-segment-elevation myocardial infarction (33%). Patients after the lockdown were younger (64.5 versus 65.5 years, P<0.001) and less likely to have diabetes (20.4% versus 24.6%, P<0.001), hypertension (52.0% versus 56.8%, P=0.001), previous myocardial infarction (23.5% versus 26.7%, P=0.008), previous PCI (24.3% versus 28.3%, P=0.001), or previous coronary artery bypass graft (4.6% versus 7.2%, P<0.001) compared with before the lockdown.
CONCLUSIONS: The lockdown in England has resulted in a significant decline in PCI procedures. Fewer patients underwent PCI for stable angina. This enabled greater capacity for urgent and emergency cases, and a reduced length of stay was seen for such patients. Significant changes in the characteristics of patients towards a lower risk phenotype were observed, particularly for non-ST-segment-elevation myocardial infarction, reflecting a more conservative approach to this cohort.

Entities:  

Keywords:  COVID-19; acute myocardial infarction; pandemics; percutaneous coronary intervention; stable angina

Mesh:

Year:  2020        PMID: 33138626     DOI: 10.1161/CIRCINTERVENTIONS.120.009654

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  15 in total

1.  Rates of Acute Myocardial Infarction During the COVID-19 Pandemic.

Authors:  Matthew T Mefford; Jaejin An; Nigel Gupta; Teresa N Harrison; Steven J Jacobsen; Ming-Sum Lee; Paul Muntner; Chileshe Nkonde-Price; Lei Qian; Kristi Reynolds
Journal:  Perm J       Date:  2021-12-13

Review 2.  Cardiovascular Health Care Implications of the COVID-19 pandemic.

Authors:  Zahra Raisi-Estabragh; Mamas A Mamas
Journal:  Cardiol Clin       Date:  2022-03-29       Impact factor: 2.410

3.  Outcomes following PCI in CABG candidates during the COVID-19 pandemic: The prospective multicentre UK-ReVasc registry.

Authors:  Thomas A Kite; Andrew Ladwiniec; Colum G Owens; Alexander Chase; Aadil Shaukat; Abdul M Mozid; Peter O'Kane; Helen Routledge; Divaka Perera; Ajay K Jain; Nick Palmer; Stephen P Hoole; Mohaned Egred; Manas K Sinha; Thomas J Cahill; Luciano Candilio; Brijesh Anantharam; Jonathan Byrne; Simon J Walsh; Margaret McEntegart; Sharon Kean; Laraib Siddique; Charley Budgeon; Nick Curzen; Colin Berry; Peter Ludman; Anthony H Gershlick
Journal:  Catheter Cardiovasc Interv       Date:  2021-05-04       Impact factor: 2.585

Review 4.  Investigating the implications of COVID-19 outbreak on systems of care and outcomes of STEMI patients: A systematic review and meta-analysis.

Authors:  William Kamarullah; Adelia Putri Sabrina; Marthin Alexander Rocky; Darius Revin Gozali
Journal:  Indian Heart J       Date:  2021-06-25

5.  Very early invasive angiography versus standard of care in higher-risk non-ST elevation myocardial infarction: study protocol for the prospective multicentre randomised controlled RAPID N-STEMI trial.

Authors:  Thomas A Kite; Amerjeet S Banning; Andrew Ladwiniec; Chris P Gale; John P Greenwood; Miles Dalby; Rachel Hobson; Shaun Barber; Emma Parker; Colin Berry; Marcus D Flather; Nick Curzen; Adrian P Banning; Gerry P McCann; Anthony H Gershlick
Journal:  BMJ Open       Date:  2022-05-03       Impact factor: 3.006

Review 6.  [COVID-19 pandemic : Effects on clinical care of cardiovascular patients in spring 2020].

Authors:  Uwe Zeymer; Anselm Gitt; Holger Thiele
Journal:  Herz       Date:  2021-02-16       Impact factor: 1.443

7.  Impact on percutaneous coronary intervention for acute coronary syndromes during the COVID-19 outbreak in a non-overwhelmed European healthcare system: COVID-19 ACS-PCI experience in Ireland.

Authors:  Niall Patrick Connolly; Andrew Simpkin; Darren Mylotte; James Crowley; Stephen O'Connor; Khalid AlHarbi; Thomas Kiernan; Sacchin Arockiam; Patrick Owens; Amal John; Gavin J Blake; Sean Fitzgerald; Diarmaid Cadogan; Liesbeth Rosseel
Journal:  BMJ Open       Date:  2021-04-02       Impact factor: 2.692

8.  COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases.

Authors:  Yuanyuan Zhang; Mingjie Wang; Xian Zhang; Tianxiao Liu; Peter Libby; Guo-Ping Shi
Journal:  Cardiol Discov       Date:  2021-11-22

Review 9.  Electrophysiology and Interventional Cardiology Procedure Volumes During the Coronavirus Disease 2019 Pandemic.

Authors:  Naga Venkata K Pothineni; Pasquale Santangeli
Journal:  Card Electrophysiol Clin       Date:  2021-10-30

Review 10.  The Impact of the COVID-19 Pandemic on Hospital Services for Patients with Cardiac Diseases: A Scoping Review.

Authors:  Mats de Lange; Ana Sofia Carvalho; Óscar Brito Fernandes; Hester Lingsma; Niek Klazinga; Dionne Kringos
Journal:  Int J Environ Res Public Health       Date:  2022-03-08       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.